Amedisys Inc

Amedisys Inc is not very popular among insiders. Amedisys Inc is a mediocre stock to choose.
Log in to see more information.
Amedisys, Inc. engages in the provision of healthcare services. It operates through the following bu...
AMED Fundamental Data by TradingView

News

Contessa Selected by Centers for Medicare & Medicaid Services to Test Medicare Dementia Care Model
Contessa Selected by Centers for Medicare & Medicaid Services to Test Medicare Dementia Care Model

Globe Newswire Guiding an Improved Dementia Experience (GUIDE) Model Aims to Increase Care Coordination, Support for CaregiversNASHVILLE, Tenn., Aug. 21, 2024 (GLOBE NEWSWIRE) -- Today, Contessa Health, a...\n more…

Amedisys just downgraded at Deutsche Bank, here's why
Amedisys just downgraded at Deutsche Bank, here's why

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

Amedisys: Hold Rating Affirmed Amidst Modest EBITDA Adjustments and Acquisition Offer
Amedisys: Hold Rating Affirmed Amidst Modest EBITDA Adjustments and Acquisition Offer

TipRanks Financial Blog Ryan Langston, an analyst from TD Cowen, maintained the Hold rating on Amedisys (AMED - Research Report). The associated price target is $101.00. R...\n more…

AMED vs. USPH: Which Stock Is the Better Value Option?
AMED vs. USPH: Which Stock Is the Better Value Option?

Zacks Investment Research Investors looking for stocks in the Medical - Outpatient and Home Healthcare sector might want to consider either Amedisys (AMED) or U.S. Physical Therapy (USPH). But which of these two stocks is...\n more…

Compared to Estimates, Amedisys (AMED) Q2 Earnings: A Look at Key Metrics
Compared to Estimates, Amedisys (AMED) Q2 Earnings: A Look at Key Metrics

Zacks Investment Research Amedisys (AMED) reported $591.19 million in revenue for the quarter ended June 2024, representing a year-over-year increase of 6.9%. EPS of $1.32 for the same period compares to $1.37 a year ago.The...\n more…

AMED Stock Earnings: Amedisys Beats EPS, Beats Revenue for Q2 2024
AMED Stock Earnings: Amedisys Beats EPS, Beats Revenue for Q2 2024

InvestorPlace InvestorPlace - Stock Market News, Stock Advice & Trading Tips\nAMED stock results show that Amedisys beat analyst estimates for earnings per share and beat on revenue for the second quarter of...\n more…